|
|
|
 |
|
|
| Review |
|
| Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? FREE |
| I Melero, R G Vile & M P Colombo |
| Abstract | Full text | PDF |
|
| 1167 |
|
| Nonviral Transfer Technology |
|
| Sodium phosphate enhances plasmid DNA expression in vivo FREE |
| J Hartikka, V Bozoukova, D Jones, R Mahajan, M K Wloch, M Sawdey, C Buchner, L Sukhu, K M Barnhart, A M Abai, J Meek, N Shen & M Manthorpe |
| Abstract | Full text | PDF |
|
| 1171 |
|
| Nonviral Transfer Technology |
|
| Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery FREE |
| D Finsinger, J-S Remy, P Erbacher, C Koch & C Plank |
| Abstract | Full text | PDF |
|
| 1183 |
|
| Viral Transfer Technology |
|
| Long-term tracking of murine hematopoietic cells transduced with a bicistronic retrovirus containing CD24 and EGFP genes FREE |
| A Kume, R Xu, Y Ueda, M Urabe & K Ozawa |
| Abstract | Full text | PDF |
|
| 1193 |
|
| Viral Transfer Technology |
|
| Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons FREE |
| S P Cregan, J MacLaurin, T F Gendron, S M Callaghan, D S Park, R J Parks, F L Graham, P Morley & R S Slack |
| Abstract | Full text | PDF |
|
| 1200 |
|
| Viral Transfer Technology |
|
| Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A FREE |
| D J Eling, P A Johnson, S Sharma, F Tufaro & T J Kipps |
| Abstract | Full text | PDF |
|
| 1210 |
|
| Acquired Disease |
|
| Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression FREE |
| J A McCart, M Puhlmann, J Lee, Y Hu, S K Libutti, H R Alexander & D L Bartlett |
| Abstract | Full text | PDF |
|
| 1217 |
|
| Acquired Disease |
|
| Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter FREE |
| E Marthinet, G Divita, J Bernaud, D Rigal & L G Baggetto |
| Abstract | Full text | PDF |
|
| 1224 |
|
| Acquired Disease |
|
Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF- B/Rel- specific decoy oligodeoxynucleotides FREE |
| M F Romano, A Lamberti, R Bisogni, P Tassone, D Pagnini, G Storti, L Del Vecchio, M C Turco & S Venuta |
| Abstract | Full text | PDF |
|
| 1234 |
|
| Acquired Disease |
|
| Ischemia/reperfusion injury-mediated down-regulation of adenovirus-mediated gene expression in a rat heart transplantation model is inhibited by co-application of a TNFRp55-Ig chimeric construct FREE |
| T Ritter, G Schröder, K Risch, A Vergopoulos, M K Shean, J Kolls, J Brock, M Lehmann & H-D Volk |
| Abstract | Full text | PDF |
|
| 1238 |
|
| Acquired Disease |
|
| Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death FREE |
| K Shimazaki, M Urabe, J Monahan, K Ozawa & N Kawai |
| Abstract | Full text | PDF |
|
| 1244 |
|
| Inherited Disease |
|
| Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector FREE |
| U Matzner, K Harzer, R D Learish, J A Barranger & V Gieselmann |
| Abstract | Full text | PDF |
|
| 1250 |
|
|
|
| July 2000, Volume 7, Number 14 |
|
| <Previous Issue Next > |
